Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
BMC Complementary Medicine and Therapies
Published in: BMC Complementary Medicine and Therapies 1/2014

Open Access 01-12-2014 | Research article

Potential anti-osteoporotic effects of herbal extracts on osteoclasts, osteoblasts and chondrocytes in vitro

Authors: Yoshiki Mukudai, Seiji Kondo, Tomoyuki Koyama, Chunnan Li, Seika Banka, Akiko Kogure, Kazunaga Yazawa, Satoru Shintani

Published in: BMC Complementary Medicine and Therapies | Issue 1/2014

Login to get access

Abstract

Background

Osteoporosis (OP) is one of the most serious diseases in the modern world, and OP patients frequently suffer from fragility fractures in the hip, spine and wrist, resulting in a limited quality of life. Although bisphosphonates (BPs) are the most effective class of anti-bone-resorptive drugs currently available and the most commonly prescribed for the clinical treatment of OP, they are known to cause serious side effects such as bisphosphonate-related osteonecrosis of the jaw. Novel therapeutic materials that can replace the use of BPs have therefore been developed.

Methods

We commenced an institutional collaborative project in which candidates of herbal extracts were selected from more than 400 bioactive herbal products for their potential therapeutic effects not only in OP, but also in oral and skeletal diseases. In the present study, we report on 3 Chinese medical herbal extracts from the root barks of Melia azedarach, Corydalis turtschaninovii, and Cynanchum atratum.

Results

All of these extracts inhibited osteoclast proliferation and induced apoptosis by up-regulation of caspase activity and increase of mitochondrial pro-apoptotic proteins expression. Furthermore, the extracts enhanced differentiation, but did not affect proliferation of both osteoblasts and chondrocytes. The osteo-inducible effect was also observed in cultured primary bone marrow cells.

Conclusions

Although these extracts have been utilized in traditional Chinese medicine for hundreds of years, there are no reports to our knowledge, on their therapeutic effects in OP. In this study, we elucidate the potency of these herbal extracts as novel candidates for OP therapy.
Appendix
Available only for authorised users
Literature
1.
Rodan GA, Martin TJ: Therapeutic approaches to bone diseases. Science. 2000, 289 (5484): 1508-1514. 10.1126/science.289.5484.1508.CrossRefPubMed
2.
Boyle WJ, Simonet WS, Lacey DL: Osteoclast differentiation and activation. Nature. 2003, 423 (6937): 337-342. 10.1038/nature01658.CrossRefPubMed
3.
Teitelbaum SL: Bone resorption by osteoclasts. Science. 2000, 289 (5484): 1504-1508. 10.1126/science.289.5484.1504.CrossRefPubMed
4.
Yoneda T, Hagino H, Sugimoto T, Ohta H, Takahashi S, Soen S, Taguchi A, Toyosawa S, Nagata T, Urade M: Bisphosphonate-related osteonecrosis of the jaw: position paper from the Allied Task Force Committee of Japanese Society for Bone and Mineral Research, Japan Osteoporosis Society, Japanese Society of Periodontology, Japanese Society for Oral and Maxillofacial Radiology, and Japanese Society of Oral and Maxillofacial Surgeons. J Bone Miner Metab. 2010, 28 (4): 365-383. 10.1007/s00774-010-0162-7.CrossRefPubMed
5.
Yamaguchi K, Shinohara C, Kojima S, Sodeoka M, Tsuji T: (2E,6R)-8-hydroxy-2,6-dimethyl-2-octenoic acid, a novel anti-osteoporotic monoterpene, isolated from Cistanche salsa. Biosci Biotechnol Biochem. 1999, 63 (4): 731-735. 10.1271/bbb.63.731.CrossRefPubMed
6.
Masuda K, Ikeuchi M, Koyama T, Yamaguchi K, Woo JT, Nishimura T, Yazawa K: Suppressive effects of Anoectochilus formosanus extract on osteoclast formation in vitro and bone resorption in vivo. J Bone Miner Metab. 2008, 26 (2): 123-129. 10.1007/s00774-007-0810-8.CrossRefPubMed
7.
Hwang YC, Jeong IK, Ahn KJ, Chung HY: The effects of Acanthopanax senticosus extract on bone turnover and bone mineral density in Korean postmenopausal women. J Bone Miner Metab. 2009, 27 (5): 584-590. 10.1007/s00774-009-0093-3.CrossRefPubMed
8.
Mok SK, Chen WF, Lai WP, Leung PC, Wang XL, Yao XS, Wong MS: Icariin protects against bone loss induced by oestrogen deficiency and activates oestrogen receptor-dependent osteoblastic functions in UMR 106 cells. Br J Pharmacol. 2010, 159 (4): 939-949. 10.1111/j.1476-5381.2009.00593.x.CrossRefPubMedPubMedCentral
9.
Kim WK, Ke K, Sul OJ, Kim HJ, Kim SH, Lee MH, Kim SY, Chung HT, Choi HS: Curcumin protects against ovariectomy-induced bone loss and decreases osteoclastogenesis. J Cell Biochem. 2011, 112 (11): 3159-3166. 10.1002/jcb.23242.CrossRefPubMed
10.
Wright LE, Frye JB, Timmermann BN, Funk JL: Protection of trabecular bone in ovariectomized rats by turmeric (Curcuma longa L.) is dependent on extract composition. J Agric Food Chem. 2010, 58 (17): 9498-9504. 10.1021/jf101873f.CrossRefPubMedPubMedCentral
11.
Folwarczna J, Zych M, Trzeciak HI: Effects of curcumin on the skeletal system in rats. Pharmacol Rep. 2010, 62 (5): 900-909.CrossRefPubMed
12.
Bharti AC, Takada Y, Aggarwal BB: Curcumin (diferuloylmethane) inhibits receptor activator of NF-kappa B ligand-induced NF-kappa B activation in osteoclast precursors and suppresses osteoclastogenesis. J Immunol. 2004, 172 (10): 5940-5947.CrossRefPubMed
13.
Li C, Yazawa K, Kondo S, Mukudai Y, Sato D, Kurihara Y, Kamatani T, Shintani S: The root bark of paeonia moutan is a potential anticancer agent in human oral squamous cell carcinoma cells. Anticancer Res. 2012, 32 (7): 2625-2630.PubMed
14.
Kim KH, Piao CJ, Choi SU, Son MW, Lee KR: New cytotoxic tetrahydroprotoberberine-aporphine dimeric and aporphine alkaloids from Corydalis turtschaninovii. Planta Med. 2010, 76 (15): 1732-1738. 10.1055/s-0030-1249972.CrossRefPubMed
15.
Saito SY, Tanaka M, Matsunaga K, Li Y, Ohizumi Y: The combination of rat mast cell and rabbit aortic smooth muscle is the simple bioassay for the screening of anti-allergic ingredient from methanolic extract of Corydalis tuber. Biol Pharm Bull. 2004, 27 (8): 1270-1274. 10.1248/bpb.27.1270.CrossRefPubMed
16.
Day SH, Wang JP, Won SJ, Lin CN: Bioactive constituents of the roots of Cynanchum atratum. J Nat Prod. 2001, 64 (5): 608-611. 10.1021/np000428b.CrossRefPubMed
17.
Lee KY, Yoon JS, Kim ES, Kang SY, Kim YC: Anti-acetylcholinesterase and anti-amnesic activities of a pregnane glycoside, cynatroside B, from Cynanchum atratum. Planta Med. 2005, 71 (1): 7-11. 10.1055/s-2005-837743.CrossRefPubMed
18.
Wu SB, Bao QY, Wang WX, Zhao Y, Xia G, Zhao Z, Zeng H, Hu JF: Cytotoxic triterpenoids and steroids from the bark of Melia azedarach. Planta Med. 2011, 77 (9): 922-928. 10.1055/s-0030-1250673.CrossRefPubMed
19.
Tan QG, Li XN, Chen H, Feng T, Cai XH, Luo XD: Sterols and terpenoids from Melia azedarach. J Nat Prod. 2010, 73 (4): 693-697. 10.1021/np1000472.CrossRefPubMed
20.
Hotokezaka H, Sakai E, Kanaoka K, Saito K, Matsuo K, Kitaura H, Yoshida N, Nakayama K: U0126 and PD98059, specific inhibitors of MEK, accelerate differentiation of RAW264.7 cells into osteoclast-like cells. J Biol Chem. 2002, 277 (49): 47366-47372. 10.1074/jbc.M208284200.CrossRefPubMed
21.
Leboy PS, Vaias L, Uschmann B, Golub E, Adams SL, Pacifici M: Ascorbic acid induces alkaline phosphatase, type X collagen, and calcium deposition in cultured chick chondrocytes. J Biol Chem. 1989, 264 (29): 17281-17286.PubMed
22.
Enomoto-Iwamoto M, Iwamoto M, Mukudai Y, Kawakami Y, Nohno T, Higuchi Y, Takemoto S, Ohuchi H, Noji S, Kurisu K: Bone morphogenetic protein signaling is required for maintenance of differentiated phenotype, control of proliferation, and hypertrophy in chondrocytes. J Cell Biol. 1998, 140 (2): 409-418. 10.1083/jcb.140.2.409.CrossRefPubMedPubMedCentral
23.
Liu G, Zhou H, Li Y, Li G, Cui L, Liu W, Cao Y: Evaluation of the viability and osteogenic differentiation of cryopreserved human adipose-derived stem cells. Cryobiology. 2008, 57 (1): 18-24. 10.1016/j.cryobiol.2008.04.002.CrossRefPubMed
24.
Tsukamoto H, Kondo S, Mukudai Y, Nagumo T, Yasuda A, Kurihara Y, Kamatani T, Shintani S: Evaluation of anticancer activities of benzo[c]phenanthridine alkaloid sanguinarine in oral squamous cell carcinoma cell line. Anticancer Res. 2011, 31 (9): 2841-2846.PubMed
25.
Yasuda A, Kondo S, Nagumo T, Tsukamoto H, Mukudai Y, Umezawa K, Shintani S: Anti-tumor activity of dehydroxymethylepoxyquinomicin against human oral squamous cell carcinoma cell lines in vitro and in vivo. Oral Oncol. 2011, 47 (5): 334-339. 10.1016/j.oraloncology.2011.03.001.CrossRefPubMed
26.
Soung do Y, Dong Y, Wang Y, Zuscik MJ, Schwarz EM, O’Keefe RJ, Drissi H: Runx3/AML2/Cbfa3 regulates early and late chondrocyte differentiation. J Bone Miner Res. 2007, 22 (8): 1260-1270. 10.1359/jbmr.070502.CrossRefPubMed
27.
Zhu M, Tang D, Wu Q, Hao S, Chen M, Xie C, Rosier RN, O’Keefe RJ, Zuscik M, Chen D: Activation of beta-catenin signaling in articular chondrocytes leads to osteoarthritis-like phenotype in adult beta-catenin conditional activation mice. J Bone Miner Res. 2009, 24 (1): 12-21. 10.1359/jbmr.080901.CrossRefPubMed
28.
29.
Parfitt AM, Mathews CH, Villanueva AR, Kleerekoper M, Frame B, Rao DS: Relationships between surface, volume, and thickness of iliac trabecular bone in aging and in osteoporosis. Implications for the microanatomic and cellular mechanisms of bone loss. J Clin Invest. 1983, 72 (4): 1396-1409. 10.1172/JCI111096.CrossRefPubMedPubMedCentral
30.
Guo C, Hou GQ, Li XD, Xia X, Liu DX, Huang DY, Du SX: Quercetin Triggers Apoptosis of Lipopolysaccharide (LPS)-induced Osteoclasts and Inhibits Bone Resorption in RAW264.7 Cells. Cell Physiol Biochem. 2012, 30 (1): 123-136. 10.1159/000339052.CrossRefPubMed
Metadata
Title
Potential anti-osteoporotic effects of herbal extracts on osteoclasts, osteoblasts and chondrocytes in vitro
Authors
Yoshiki Mukudai
Seiji Kondo
Tomoyuki Koyama
Chunnan Li
Seika Banka
Akiko Kogure
Kazunaga Yazawa
Satoru Shintani
Publication date
01-12-2014
Publisher
BioMed Central
Published in
BMC Complementary Medicine and Therapies / Issue 1/2014
Electronic ISSN: 2662-7671
DOI
https://doi.org/10.1186/1472-6882-14-29

Other articles of this Issue 1/2014

BMC Complementary Medicine and Therapies 1/2014 Go to the issue

Research article

Chemical composition and biological activity of Rubus idaeus shoots – a traditional herbal remedy of Eastern Europe

Research article

Biofilm formation of Clostridium difficile and susceptibility to Manuka Honey

Research article

Fermented soshiho-tang with Lactobacillus plantarum enhances the antiproliferative activity in vascular smooth muscle cell

Research article

Evaluation of antimalarial activity of leaves of Acokanthera schimperi and Croton macrostachyus against Plasmodium berghei in Swiss albino mice

Research article

Effects of Eleutheroside B and Eleutheroside E on activity of cytochrome P450 in rat liver microsomes

Research article

Decrease of a specific biomarker of collagen degradation in osteoarthritis, Coll2-1, by treatment with highly bioavailable curcumin during an exploratory clinical trial